Treatment of Patients With Anxiety Disorder (0777-022)

NCT00539578 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

270

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: MK0777
DRUG: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC